Form 4 for NVAX NOVAVAX INC
Accepted 2024-03-12 00:00:00 ET · period of report 2024-03-10 · accession 0001104659-24-033620 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-12 | 2024-03-10 | NVAX | Dubovsky Filip | Pres, R, D | F - Tax | $5.45 | -2,597 | 66.6K | -4% | -$14.2K |
| D | 2024-03-12 | 2024-03-10 | NVAX | Dubovsky Filip | Pres, R, D | M - OptEx | — | +5,376 | 69.2K | +8% | — |
| D | 2024-03-12 | 2024-03-10 | NVAX | Dubovsky Filip | Pres, R, D | M - OptEx | $0.00 | -5,376 | 5,376 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-10 | F | D | 2,597 | $5.45 | 66,613 | D | — | — | |
| 2 | Common | Common Stock | 2024-03-10 | M | A | 5,376 | — | 69,210 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. |
| 3 | Derivative | Restricted Stock Units | 2024-03-10 | M | D | 5,376 | $0.00 | 5,376 | D | — · — to — | 5,376 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. (F2) The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the March 10, 2022 grant date, in each case subject to continued employment through such vesting date |